189531. lajstromszámú szabadalom • Eljárás alanin-származékok előállítására
189 531 Szám n R1 RJ R3 Mód szer MMR spektrum 310 1 —ch3 (4-imidazolil)-CH2—-c2h5 B 7,7-7,lm (6H); 2,9m (2H); l,2d (3H) 311 0-ch3 —CH2—CH2-fenii-c2h5 B 7,2-6,5m (9H); 2,7m (2H); l,7m (2H); l,2d (3H) 312 0-ch3 —CH2—CH2 —(4-klórfenil) —H B 7,5-6,5m (8H); 2,7m (2H); l,7m (2H); l,2d (3H) 313 0-ch3 —CH2—CH2-2,6-diklórfenil) —H B 7,6-6,5m (7H); 2,8m (2H); l,7m (2H); l,2d (3H) 314 0 —ch3 —CH2—CH2—(2-pirrolil) —H B 7,3-6,0m (7H); 2,8m (2H); l,7m (2H); l,2d (3H) 315 0-ch3 —CH2—CH,—(2-tienil) —H B 7,3-6,5m (7H); 2,9m (2H); l,7m (2H); l,2d (3H) 316 0-ch3 —CH2—CH2 —(3-piridil) —H B 8,6-6,5m (8H); 2,9m (2H); l,7m (2H); l,2d (3H) 317 0-ch3 (3-indol)-CH2—CH2—-c2h5 B 7,8-6,5m (10H); 2,9m (2H); l,7m (2H); l,2d (3H) 318 0--ch3 ch3 CH—CH2-fenil-c2h5 B 7,2-6,5m (9H); 2,9m (2H); l,8m (1H); l,2d (3H); l,ld (3H) 319 0 — CH3 . —CH2—CHj—CHj—(4- klór-fenil)-c2h5 B 7,4-6,5m (8H); 2,7-2,3m (2H); l,8-l,3m (4H); l,2d (3H) 320 0 -ch3 ch3 1 —ch2—ch2—c— 1 ch3 —(4-metoxi-fenil)-c2h5 B 7,3-6,3m (8H); 3,9s (3H); l,9-l,2m (4H); l,2d (3H); 1,0s (6H) 321 0 -ch3 —CH2—CH2 —(2-metoxi- 5-klór-fenil)-c2h5 B 7,2-6,3m (7H); 3,9s (3H); 2,7m (2H); 1,8m (2H); l,2d (3H) _ 322 0 -ch3 —CH2—(3-indol)-QHS B 7,8-ó,5m (IOH); 2,9m (2H); l,2d (3H) 323 0 -ch3 (4-imidazolil)-CH2—CH2-c2H5 B 7,7-6,5m (6H); 2,9m (2H); l,7m (2H); l,2d (3H) 324 0 -CH3 (4-imidazolil)-CH2—-c2h5 B 7,7-6,5m (6H); 2,9m (2H); l,2d (3H) 325 1 -CH3 (CH3)2—CH—CH2— —CH2—CH2—-c2h5 A l,9-l,3m (7H); l,2d (3H); 0,9d (6H) 326 1 h2n— -(CH2)4— (CH3)2CH—CH2—CH2—-C2Hs B 2,4m (2H); 1,9-1,3m (HH); 0,9d(6H) 327 1 h2n— -(CH2)3-(CH3)2CH—ch2—-c2h5 B 2,4m (2H); l,9-l,3m (7H); 0,9d (6H) 328 0 fch2— (CH3)2CH—-c2h5 B 4,3dd (2H); 1,9m (1H); 0,9d (6H) 329 1 —CH2—CH — 1 ch3 ciklohexil-CH2 —H A l,9-l,2m (16H); l,Od + t (6H) 330 1 -ch3 (2-naftil)-CH2—CH2—-C2Hs A 7,8-7,0m (11 H); 2,7m (2H); l,5m (2H); l,2d (3H)
